• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一名患有难治性脑多药耐药结核病的免疫功能低下患者中使用γ干扰素辅助治疗。

Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain.

作者信息

Raad I, Hachem R, Leeds N, Sawaya R, Salem Z, Atweh S

机构信息

Department of Medical Specialties, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.

出版信息

Clin Infect Dis. 1996 Mar;22(3):572-4. doi: 10.1093/clinids/22.3.572.

DOI:10.1093/clinids/22.3.572
PMID:8852983
Abstract

We describe a patient with acute lymphocytic leukemia and multidrug-resistant tuberculosis of the brain and spinal cord. Despite treatment with six antituberculous drugs and a steroid medication for 11 months, there was no appreciable clinical or radiological improvement in the patient's condition. Within 5 months of initiating adjunctive therapy with IFN-gamma and granulocyte colony stimulating factors, substantial neurological and radiological improvement was noted. Therapy with IFN-gamma was continued for 12 months, resulting in complete resolution of the lesions in the brain and spinal cord.

摘要

我们描述了一名患有急性淋巴细胞白血病以及脑和脊髓耐多药结核病的患者。尽管使用六种抗结核药物和一种类固醇药物治疗了11个月,但患者的病情在临床和影像学上均无明显改善。在开始使用γ干扰素和粒细胞集落刺激因子进行辅助治疗的5个月内,观察到神经功能和影像学有显著改善。γ干扰素治疗持续了12个月,导致脑和脊髓病变完全消退。

相似文献

1
Use of adjunctive treatment with interferon-gamma in an immunocompromised patient who had refractory multidrug-resistant tuberculosis of the brain.在一名患有难治性脑多药耐药结核病的免疫功能低下患者中使用γ干扰素辅助治疗。
Clin Infect Dis. 1996 Mar;22(3):572-4. doi: 10.1093/clinids/22.3.572.
2
[Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].基于连续耐药检测结果观察的耐多药结核分枝杆菌出现的归因因素
Kekkaku. 1998 Jul;73(7):471-6.
3
Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?利福平单耐药结核病的检测与治疗方案:异烟肼的作用是什么?
Int J Tuberc Lung Dis. 2013 Jun;17(6):849-50. doi: 10.5588/ijtld.13.0066.
4
[Reasons for drug-resistant tuberculosis emergence].[耐多药结核病出现的原因]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jun;30(6):403-5.
5
Mycobacterium tuberculosis drug resistance: a call to action.结核分枝杆菌耐药性:行动呼吁
Int J Tuberc Lung Dis. 1998 Aug;2(8):609-11.
6
High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.中国贵州省遵义市耐多药结核病的高流行率。
J Antimicrob Chemother. 2011 Oct;66(10):2435-7. doi: 10.1093/jac/dkr319. Epub 2011 Jul 26.
7
Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.雅培实时MTB利福平/异烟肼耐药性检测法的分析及临床性能特征,该检测法用于检测肺部标本中耐利福平和异烟肼的结核分枝杆菌。
Tuberculosis (Edinb). 2016 Dec;101:137-143. doi: 10.1016/j.tube.2016.09.006. Epub 2016 Sep 22.
8
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].[实验与临床中分枝杆菌对抗结核药物耐药性降低:近期及长期结果]
Probl Tuberk Bolezn Legk. 2007(2):31-8.
9
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.肺切除术联合基于异烟肼和利福平的药物治疗用于耐多药和广泛耐药结核病患者。
Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.
10
[Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis].[微芯片技术在结核分枝杆菌耐药性检测中的临床价值]
Probl Tuberk. 2002(6):21-4.

引用本文的文献

1
: Pathogenesis and therapeutic targets.发病机制与治疗靶点。
MedComm (2020). 2023 Sep 4;4(5):e353. doi: 10.1002/mco2.353. eCollection 2023 Oct.
2
Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response.结核病中的表观遗传学:宿主免疫反应的免疫调节
Vaccines (Basel). 2022 Oct 18;10(10):1740. doi: 10.3390/vaccines10101740.
3
Antibiotic Resistance to and Potential Use of Natural and Biological Products as Alternative Anti-Mycobacterial Agents.抗生素耐药性以及天然和生物制品作为替代抗分枝杆菌药物的潜在用途。
Antibiotics (Basel). 2022 Oct 18;11(10):1431. doi: 10.3390/antibiotics11101431.
4
Therapeutic potential of interferon-gamma in tuberculosis.γ-干扰素在结核病中的治疗潜力
ADMET DMPK. 2022 Feb 14;10(1):63-73. doi: 10.5599/admet.1078. eCollection 2022.
5
Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis.干扰素在结核病诊断、疫苗和治疗研发中的作用。
J Immunol Res. 2017;2017:5212910. doi: 10.1155/2017/5212910. Epub 2017 Jun 20.
6
Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent.人干扰素-α和干扰素-λ亚型的表达谱与配体和细胞有关。
Immunol Cell Biol. 2012 Sep;90(8):774-83. doi: 10.1038/icb.2011.109. Epub 2012 Jan 17.
7
Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study.辅助性γ干扰素治疗肺部非典型分枝杆菌病患者:一项随机、双盲、安慰剂对照研究。
BMC Infect Dis. 2008 Feb 11;8:17. doi: 10.1186/1471-2334-8-17.
8
Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection.鼻内注射干扰素γ可延长小鼠被动IgA抗体对结核分枝杆菌肺部感染的保护作用。
Clin Exp Immunol. 2006 Mar;143(3):467-73. doi: 10.1111/j.1365-2249.2006.03012.x.
9
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.耐药性肺结核患者辅助使用γ干扰素的一项初步研究。
BMC Infect Dis. 2004 Oct 22;4:44. doi: 10.1186/1471-2334-4-44.
10
Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis.雾化干扰素-γ治疗耐多药难治性肺结核6个月的疗效观察
J Korean Med Sci. 2004 Apr;19(2):167-71. doi: 10.3346/jkms.2004.19.2.167.